Indian female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 5.4% during the forecast period. The growth of the market is owing to the rising population, growth in healthcare infrastructure and so on. Increasing healthcare infrastructure is estimated to be one of the major factors to drive the growth of the female infertility diagnosis-treatment market. Over the past few years, considerable growth in the healthcare sector in India has been witnessed.
Rising disposable incomes and easier access to high-quality healthcare facilities and increasing awareness towards health and personal hygiene are estimated to be the major factors that are boosting this market growth. Further, increasing medical tourism in India due to the presence of high-class healthcare facilities and low cost of treatment is again contributing significantly towards the growth of the market. The presence of quality hospitals that are offering this treatment facility along with available skilled medical professionals in India is anticipated to promote the market growth within the country.
To Request a Sample of our Report on Indian Female Infertility Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/indian-female-infertility-market
Indian female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.
Some of the major players operating in Indian female infertility diagnosis and treatment market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in Indian market.
(Get 15% Discount on Buying this Report)
A full Report of Indian Female Infertility Diagnosis and Treatment Market is Available @ https://www.omrglobal.com/industry-reports/indian-female-infertility-market
Indian Female Infertility Diagnosis and Treatment Market Segmentation
By Diagnosis
- 5Ovulation Testing
- Hysterosalpingography (HSG)
- Hysteroscopy
- Imaging Testing
- Ovarian Reserve Testing
- Hormonal Level Testing
- Genetic Testing
- Others (Laparoscopy)
By Treatment
- Drugs
- Surgery
- Intrauterine Insemination (IUI)
- Assisted Reproductive Technology (ART)
By End-User
- Hospitals and Clinics
- Homecare
- Pathology and Diagnostic Centers
Company Profiles
- Abbott Laboratories, Inc.
- Bayer AG
- Bristol-Myers Squibb Co.
- Cadila Pharmaceuticals Ltd.
- Centogene AG
- Cipla Ltd.
- Cook Medical, Inc.
- Cordex Pharma, Inc.
- Eli Lilly and Co.
- Endo Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Intas Pharmaceuticals Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
